DGAP-Adhoc: UMS United Medical Systems International AG: UMS AG confirms preliminary figures for 2013


 
UMS United Medical Systems International AG / Key word(s): Forecast/Final Results 25.03.2014 11:36 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- UMS AG confirms preliminary figures for 2013 - Earnings should be between 50 and 55 cents per share in 2014 - Management Board and Supervisory Board propose unchanged dividend of 55 cents per share for 2013 Hamburg, March 25, 2014 - UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) is confirming the preliminary 2013 figures published on February 20, 2014. The Company, which offers transportable service concepts in selected fields of medicine, achieved adjusted earnings per share of 52 cents in fiscal 2013. Consolidated sales under IFRS were EUR 39.8 million. Overall, UMS AG expects constant macroeconomic conditions in the U.S. and a decreasing uncertainty with respect to the country's healthcare reform in 2014. However, given the long, harsh winter in the nation's north, the Company anticipates a slow first half of the year. The Company projects sales and earnings on prior years level - provided exchange rates remain on current level (1,38 Euro) - and earnings per share of between 50 and 55 cents in fiscal 2014. The Management Board and Supervisory Board of UMS AG will propose a dividend for 2013 of 55 cents per share at the Annual General Meeting to be held in Hamburg on June 4, 2014. This amount is unchanged from a year earlier. The distribution will be paid out of the contribution account for tax purposes, and no taxes will be withheld. The annual report of UMS AG is due to be published in both German and English on April 15, 2014. Once published, it will be available for download at www.umsag.com. About UMS AG UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the mobile deployment of high-class medical systems and markets a comprehensive range of full-service solutions for hospitals and specialists. The forward-looking concepts include complete services for the customer, covering everything from system management to the provision of trained application specialists. The UMS Group currently has around 219 employees worldwide and serves over 900 customers. Contact Astrid Soltau, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-mail: [email protected] 25.03.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: UMS United Medical Systems International AG Borsteler Chaussee 53 22453 Hamburg Germany Phone: +49 (0)40 - 500 177 - 00 Fax: +49 (0)40 - 500 177 - 77 E-mail: [email protected] Internet: www.umsag.com ISIN: DE0005493654 WKN: 549365 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN
©boersengefluester.de
WKN Kurs in € Einschätzung Börsenwert in Mio. €
0,000 0,00
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 0,00
KBV KCV KUV EV/EBITDA
0,00 0,00 0,00 0,00
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,00% 0,00% 0,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu UMS United Medical Systems International AG  ISIN: DE0005493654 können Sie bei EQS abrufen


in Auflösung , 549365